RxAntiarrhythmicsLow Cost

Dofetilide Cost & Price Guide

Also sold as: DOFETILIDE

As a brand-name drug, Dofetilide can be very expensive. Look for manufacturer patient assistance programs or discount cards to help reduce the cost.

Typical Cost
$2,000–$4,000/month

Per month, without insurance

Generic
Not Available

Only brand-name versions currently available

Coupons
Available

Discount coupons may reduce out-of-pocket costs

Find the Lowest Price for Dofetilide

Free

Compare prices at 67,000+ pharmacies — no membership, no sign-up required.

Powered by RxGo · Accepted at CVS, Walgreens, Walmart, Costco & more · Save up to 80%

Cost Overview

As a brand-name drug, Dofetilide can be very expensive. Look for manufacturer patient assistance programs or discount cards to help reduce the cost.

Generic vs. Brand-Name Price

VersionTypical Monthly CostNotes
DOFETILIDE(brand)$2,000–$4,000/monthCheck manufacturer patient assistance programs

Ways to Save on Dofetilide

Prescription Discount Cards

Free discount programs like GoodRx, RxSaver, and NeedyMeds can reduce the cost of dofetilide at most pharmacies. Compare prices before filling.

90-Day Supply

Ordering a 90-day supply through a mail-order pharmacy often costs less per dose than monthly fills. Check with your insurance plan or pharmacy benefit manager.

Patient Assistance Programs

If you're uninsured or underinsured, the manufacturer may offer a patient assistance program (PAP) that provides dofetilide at low or no cost. Visit NeedyMeds.org or the manufacturer's website.

Insurance Coverage

Most insurance plans, including Medicare Part D and Medicaid, cover dofetilide . Coverage and copay amounts vary by plan tier and formulary. Contact your insurance provider or check your plan's drug formulary to confirm coverage.

Medicare Part D
Usually covered; tier varies by plan
Medicaid
Generally covered; check your state plan
Commercial Insurance
Typically covered; copay varies

Find the Best Price

Frequently Asked Questions About Dofetilide Cost

What is DOFETILIDE used for?

INDICATIONS & USAGE Maintenance of Normal Sinus Rhythm (Delay in AF/AFl Recurrence) Dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. Because dofetilide can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. In general, antiarrhythmic therapy for atrial…

What is the recommended dosage for DOFETILIDE?

DOSAGE & ADMINISTRATION Therapy with dofetilide must be initiated (and, if necessary, re-initiated) in a setting that provides continuous electrocardiographic (ECG) monitoring and in the presence of personnel trained in the management of serious ventricular arrhythmias. Patients should continue to be monitored in this way for a minimum of three days. Additionally, patients should not be discharged within 12 hours of electrical or pharmacological conversion to normal sinus rhythm. The dose of dofetilide must be individualized according to calculated creatinine clearance and QTc. (QT interval…

Who should not take DOFETILIDE?

CONTRAINDICATIONS Dofetilide capsules are contraindicated in patients with congenital or acquired long QT syndromes. Dofetilide capsules should not be used in patients with a baseline QT interval or QTc >440 msec (500 msec in patients with ventricular conduction abnormalities). Dofetilide capsules are also contraindicated in patients with severe renal impairment (calculated creatinine clearance <20 mL/min). The concomitant use of verapamil or the cation transport system inhibitors cimetidine, trimethoprim (alone or in combination with sulfamethoxazole), or ketoconazole with dofetilide…

What are the side effects of DOFETILIDE?

ADVERSE REACTIONS The dofetilide clinical program involved approximately 8,600 patients in 130 clinical studies of normal volunteers and patients with supraventricular and ventricular arrhythmias. Dofetilide was administered to 5,194 patients, including two large, placebo-controlled mortality trials (DIAMOND CHF and DIAMOND MI) in which 1,511 patients received dofetilide for up to three years. In the following section, adverse reaction data for cardiac arrhythmias and non-cardiac adverse reactions are presented separately for patients included in the supraventricular arrhythmia development…

More Dofetilide Information

Top 50 Most Prescribed Medications

Common dosages & current prices via RxGo

Get the RxGo app — free prescription discounts on the go

Works at 67,000+ pharmacies · No membership needed

Download

Medical Disclaimer

The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.